Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1669-1676

  Gervasoni, Annalisa ^a   Sandri, Maria Teresa ^d   Nascimbeni, Riccardo ^c   Zorzino, Laura ^d   Cassatella, Maria Cristina ^d   Baglioni, Luigi ^a   Panigara, Sara ^b   Gervasi, Maria ^b   Di Lorenzo, Diego ^b   Parolini, Ornella ^a  

^a Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

^b Ospedale Civile di Brescia   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

CellSearch assay; Circulating tumor cells; Colorectal cancer; dHPLC; Gene mutation; Method comparison; Multimarker RT PCR assay

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CELL ASSAY; CELLSEARCH ASSAY; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; CELL SEPARATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 79954496657     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1231     Document Type: Article

References (42)

1. Boyle P and Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 16: 481-488, 2005.
2. Fehm T, Sagalowsky A, Clifford E, et al: Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 8: 2073-2084, 2002. (Pubitemid 34753576)
3. Guadagni F, Kantor J, Aloe S, et al: Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res 61: 2523-2532, 2001. (Pubitemid 32685833)
4. Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL and Zhang X: Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol 10: 804-808, 2004.
5. Hampton R, Walker M, Marshall J and Juhl H: Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. Oncogene 21: 7817-7823, 2002. (Pubitemid 35398839)
6. Ring A, Smith IE and Dowsett M: Circulating tumour cells in breast cancer. Lancet Oncol 5: 79-88, 2004. (Pubitemid 38145890)
7. Guller U, Zajac P, Schnider A, et al: Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236: 768-766, 2002.
8. Weigelt B, Bosma AJ, Hart AA, Rodenhuis S and van't Veer LJ: Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients. Br J Cancer 88: 1091-1094, 2003. (Pubitemid 36560781)
9. Cristofanilli M, Budd GT, Ellis MJ, et al: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791, 2004. (Pubitemid 39095313)
10. Cristofanilli M, Hayes DF, Budd GT et al: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23: 1420-1430, 2005.
11. Cristofanilli M, Broglio KR, Guarneri V, et al: Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 7: 471-479, 2007. (Pubitemid 46424284)
12. Austrup F, Uciechowski P, Eder C, et al: Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients. Br J Cancer 83: 1664-1673, 2000. (Pubitemid 32001712)
13. Soria JC, Gauthier LR, Raymond E, et al: Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 5: 971-975, 1999. (Pubitemid 29233209)
14. Reinhold U, Ludtke-Handjery HC, Schnautz S, Kreysel HW and Abken H: The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 108: 166-169, 1997. (Pubitemid 27061027)
15. Nole F, Munzone E, Zorzino L, et al: Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann Oncol 19: 891-897, 2008. (Pubitemid 351627303)
16. Pierga JY, Bidard FC, Mathiot C, et al: Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 14: 7004-7010, 2008.
17. Danila DC, Heller G, Gignac GA, et al: Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 13: 7053-7058, 2007. (Pubitemid 350276887)
18. De Bono JS, Scher HI, Montgomery RB, et al: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14: 6302-6309, 2008.
19. Cohen SJ, Punt CJ, Iannotti N, et al: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26: 3213-3221, 2008.
20. Apostolaki S, Perraki M, Pallis A, et al: Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance. Ann Oncol 18: 851-858, 2007. (Pubitemid 47054081)
21. Xenidis N, Ignatiadis M, Apostolaki S, et al: Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Oncol 27: 2177-2184, 2009.
22. Ginestier C, Hur MH, Charafe-Jauffret E, et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567, 2007. (Pubitemid 350056407)
23. Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D and Georgoulias V: Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 288: 99-106, 2010.
24. Trumpp A and Wiestler OD: Mechanisms of Disease: cancer stem cells - targeting the evil twin. Nat Clin Pract Oncol 5: 337-347, 2008. (Pubitemid 351780950)
25. Zach O and Lutz D: Tumor cell detection in peripheral blood and bone marrow. Curr Opin Oncol 18: 48-56, 2006. (Pubitemid 43740450)
26. Zieglschmid V, Hollmann C and Bocher O: Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci 42: 155-196, 2005. (Pubitemid 41647727)
27. Paterlini-Brechot P and Benali NL: Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253: 180-204, 2007. (Pubitemid 47017533)
28. Schuetz CS, Bonin M, Clare SE, et al: Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res 66: 5278-5286, 2006. (Pubitemid 43844952)
29. Takayama T, Miyanishi K, Hayashi T, Sato Y and Niitsu Y: Colorectal cancer: genetics of development and metastasis. J Gastroenterol 41: 185-192, 2006.
30. Allard WJ, Matera J, Miller MC, et al: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Clin Cancer Res 10: 6897-6904, 2004. (Pubitemid 39383039)
31. Budd GT, Cristofanilli M, Ellis MJ, et al: Circulating tumor cells versus imaging - predicting overall survival in metastatic breast cancer. Clin Cancer Res 12: 6403-6409, 2006. (Pubitemid 44799711)
32. De Giorgi U, Valero V, Rohren E, et al: Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol 27: 3303-3311, 2009.
33. Van der Auwera I, Peeters D, Benoy EH, et al: Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 102: 276-284, 2010.
34. Deng G, Herrler M, Burgess D, Manna E, Krag D and Burke JF: Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res 10: R69, 2008.
35. Helo P, Cronin AM, Danila DC, et al: Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin Chem 55: 765-773, 2009.
36. Balic M, Dandachi N, Hofmann G, et al: Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 68: 25-30, 2005. (Pubitemid 41566360)
37. Konigsberg R, Gneist M, Jahn-Kuch D, et al: Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods. Cancer Lett 293: 117-123, 2010.
38. Gervasoni A, Monasterio Munoz RM, Wengler GS, Rizzi A, Zaniboni A and Parolini O: Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett 263: 267-279, 2008.
39. Xiao W and Oefher PJ: Denaturing high-performance liquid chromatography: a review. Hum Mutat 17: 439-474, 2001. (Pubitemid 32480082)
40. Cremone si L, Stenirri S, Fermo I, Paroni R, Ferrari M, Cazzola M and Arosio P: Denaturing HPLC analysis of DNA deletions and insertions. Hum Mutat 22: 98-102, 2003.
41. Sieuwerts AM, Kraan J, Bolt J, et al: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101: 61-66, 2009.
42. Bustin SA, Siddiqi S, Ahmed S, Hands R and Dorudi S: Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int J Cancer 108: 412-417, 2004. (Pubitemid 37549607)